As in prior experiments with GEP44, no indicators of nausea or malaise (e.g., changes in responsiveness, behavior, coat appearance, or facial expressions such as orbital tightening and nose/cheek flattening) were observed with GEP12 dosing
Additionally, while my weight, energy levels, and anxiety all improved once I started on thyroid medications, I also had many other symptoms that were not thyroid related, per se, and not responsive to thyroid treatment, like my acid reflux , irritable bowel syndrome , joint pain , and fatigue
Rong et al., 2023)
In fact, its FDA-approved under the brand name Zepbound for chronic weight management. #PharmD #DrugUpdate #Mounjaro #Tirzepatide #ClinicalPharmacy #PharmacyPractice #DiabetesCare #Pharmacology #HealthcareInnovation #PatientCounseling To view or add a comment, sign in Dapagliflozin Dapagliflozin is an oral anti-diabetic medication belonging to the class SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors)